PHILADELPHIA, April 3, 2024 /PRNewswire/ Carisma Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced.
Press Release Stockholm, Sweden, December 5, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced it will present the.
Terumo Blood and Cell Technologies, a medical tech company, and BioCentriq, a cell therapy contract development and manufacturing organization (CDMO), are working together to demonstrate the capabilities of Terumo’s automated cell and gene therapy platforms to accelerate CAR-T cell development.
Terumo Blood and Cell Technologies, a medical tech company, and BioCentriq, a cell therapy contract development and manufacturing organization (CDMO), are working together to demonstrate the capabilities of Terumo’s automated cell and gene therapy platforms to accelerate CAR-T cell development.